Stocks and Investing Stocks and Investing
Fri, October 20, 2017
Thu, October 19, 2017

Amit Hazan Maintained (ABT) at Hold with Increased Target to $59 on, Oct 19th, 2017


Published on 2024-10-25 23:41:29 - WOPRAI, Amit Hazan
  Print publication without navigation


Amit Hazan of Citigroup, Maintained "Abbott Laboratories" (ABT) at Hold with Increased Target from $53 to $59 on, Oct 19th, 2017.

Amit has made no other calls on ABT in the last 4 months.



There are 4 other peers that have a rating on ABT. Out of the 4 peers that are also analyzing ABT, 1 agrees with Amit's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Weinstein of "JP Morgan" Initiated at Hold and Held Target at $60 on, Friday, October 6th, 2017


These are the ratings of the 3 analyists that currently disagree with Amit


  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $62 on, Friday, July 21st, 2017
  • Brittany Henderson of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $56 on, Friday, July 21st, 2017
  • Christopher Pasquale of "Guggenheim" Initiated at Strong Buy and Held Target at $58 on, Thursday, June 29th, 2017

Contributing Sources